Recommendations for the use of nuclear medicine imaging in patients with neuroblastoma.

IF 2.8 3区医学 Q2 ONCOLOGY

Clinical & Translational Oncology Pub Date : 2024-11-07 DOI:10.1007/s12094-024-03755-3

Raquel Sánchez-Vañó, Julia Balaguer, Isabel Borrego-Dorado, Alba Esteban-Figueruelo, Cristina Gámez, Raquel Hladun, Ricardo López-Almaraz, Mercedes L Llempén, Sonia Rodado, Pedro M Rubio-Aparicio

{"title":"Recommendations for the use of nuclear medicine imaging in patients with neuroblastoma.","authors":"Raquel Sánchez-Vañó, Julia Balaguer, Isabel Borrego-Dorado, Alba Esteban-Figueruelo, Cristina Gámez, Raquel Hladun, Ricardo López-Almaraz, Mercedes L Llempén, Sonia Rodado, Pedro M Rubio-Aparicio","doi":"10.1007/s12094-024-03755-3","DOIUrl":null,"url":null,"abstract":"<p><p>Neuroblastoma (NB) is the most common extracranial solid cancer in children. Despite intensive multimodality treatment, long-term survival of patients with high-risk NB, which comprises more than half of all cases, remains poor. Nuclear medicine is key in diagnosis, staging, response assessment and long-term follow-up of NB. The emergence of novel tracers and the increasing complexity of studies require updated guidelines for nuclear medicine imaging in NB. Standardising diagnostic techniques are essential for improving study comparability and ensuring test quality. This article aims to provide a comprehensive review of NB radionuclide diagnostic imaging, including its characteristics, accuracy, advantages, and limitations. It offers practical recommendations to multidisciplinary teams responsible for treating patients with NB. This review summarises the opinions of leading experts from the Neuroblastoma Spanish Group within the Spanish Society of Paediatric Haematology and Oncology (SEHOP) and the Spanish Society of Nuclear Medicine and Molecular Imaging (SEMNIM).</p>","PeriodicalId":50685,"journal":{"name":"Clinical & Translational Oncology","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical & Translational Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12094-024-03755-3","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Neuroblastoma (NB) is the most common extracranial solid cancer in children. Despite intensive multimodality treatment, long-term survival of patients with high-risk NB, which comprises more than half of all cases, remains poor. Nuclear medicine is key in diagnosis, staging, response assessment and long-term follow-up of NB. The emergence of novel tracers and the increasing complexity of studies require updated guidelines for nuclear medicine imaging in NB. Standardising diagnostic techniques are essential for improving study comparability and ensuring test quality. This article aims to provide a comprehensive review of NB radionuclide diagnostic imaging, including its characteristics, accuracy, advantages, and limitations. It offers practical recommendations to multidisciplinary teams responsible for treating patients with NB. This review summarises the opinions of leading experts from the Neuroblastoma Spanish Group within the Spanish Society of Paediatric Haematology and Oncology (SEHOP) and the Spanish Society of Nuclear Medicine and Molecular Imaging (SEMNIM).

查看原文本刊更多论文

对神经母细胞瘤患者使用核医学成像的建议。

神经母细胞瘤（NB）是儿童最常见的颅外实体瘤。尽管进行了强化多模式治疗，但高危 NB 患者（占所有病例的一半以上）的长期生存率仍然很低。核医学是NB诊断、分期、反应评估和长期随访的关键。新型示踪剂的出现和研究复杂性的增加要求更新 NB 核医学成像指南。诊断技术的标准化对于提高研究的可比性和确保检测质量至关重要。本文旨在全面回顾 NB 放射性核素诊断成像，包括其特点、准确性、优势和局限性。它为负责治疗 NB 患者的多学科团队提供了实用的建议。这篇综述总结了西班牙儿科血液学和肿瘤学学会（SEHOP）神经母细胞瘤西班牙小组以及西班牙核医学和分子成像学会（SEMNIM）主要专家的意见。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical & Translational Oncology 医学-肿瘤学

CiteScore

6.20

自引率

2.90%

发文量

240

审稿时长

1 months

期刊介绍： Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of new targets for cancer therapy, and new technologies for research and treatment of cancer are the major themes covered by the educational series. Full research articles on a broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.